These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27246780)

  • 1. Extensive Shared Chemosensitivity between Malaria and Babesiosis Blood-Stage Parasites.
    Paul AS; Moreira CK; Elsworth B; Allred DR; Duraisingh MT
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5059-63. PubMed ID: 27246780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of malaria and babesiosis parasites by putative red blood cell targeting small molecules.
    Groomes PV; Paul AS; Duraisingh MT
    Front Cell Infect Microbiol; 2024; 14():1304839. PubMed ID: 38572319
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Vydyam P; Chand M; Gihaz S; Renard I; Heffernan GD; Jacobus LR; Jacobus DP; Saionz KW; Shah R; Shieh H-M; Terpinski J; Zhao W; Cornillot E; Ben Mamoun C
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0042324. PubMed ID: 39136469
    [No Abstract]   [Full Text] [Related]  

  • 4. Curcuma as a parasiticidal agent: a review.
    Haddad M; Sauvain M; Deharo E
    Planta Med; 2011 Apr; 77(6):672-8. PubMed ID: 21104602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular adhesive phenomena in apicomplexan parasites of red blood cells.
    Cooke BM; Mohandas N; Cowman AF; Coppel RL
    Vet Parasitol; 2005 Sep; 132(3-4):273-95. PubMed ID: 16087297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of
    Rizk MA; El-Sayed SAE; Alkhoudary MS; Alsharif KF; Abdel-Daim MM; Igarashi I
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.
    Richier E; Biagini GA; Wein S; Boudou F; Bray PG; Ward SA; Precigout E; Calas M; Dubremetz JF; Vial HJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3381-8. PubMed ID: 17005821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aims, concepts and recent results of research on malaria parasites.
    Wernsdorfer WH
    Parassitologia; 1984 Dec; 26(3):219-45. PubMed ID: 6400652
    [No Abstract]   [Full Text] [Related]  

  • 9. Babesia rodhaini and Plasmodium berghei. A highly active series of chlorophenoxyalkoxy-substituted diamino-dihydrotriazines against experimental infections in mice.
    Knight DJ
    Ann Trop Med Parasitol; 1981 Feb; 75(1):1-6. PubMed ID: 7023398
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: A review.
    Rizk MA; El-Sayed SAE; El-Khodery S; Yokoyama N; Igarashi I
    Vet Parasitol; 2019 Oct; 274():108895. PubMed ID: 31494399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites.
    Chang ZW; Malleret B; Russell B; Rénia L; Claser C
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6859-6866. PubMed ID: 27600050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
    Ashton TD; Devine SM; Möhrle JJ; Laleu B; Burrows JN; Charman SA; Creek DJ; Sleebs BE
    J Med Chem; 2019 Dec; 62(23):10526-10562. PubMed ID: 31385706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do babesiosis and malaria share a common disease process?
    Clark IA; Jacobson LS
    Ann Trop Med Parasitol; 1998 Jun; 92(4):483-8. PubMed ID: 9683899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the apicoplast: apicoplast-targeting drugs and malaria vaccine development.
    Low LM; Stanisic DI; Good MF
    Microbes Infect; 2018; 20(9-10):477-483. PubMed ID: 29287981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Babesia duncani, a Model Organism for Investigating Intraerythrocytic Parasitism and Novel Antiparasitic Therapeutic Strategies.
    Fang T; Ben Mamoun C
    J Infect Dis; 2024 Jul; 230(1):263-270. PubMed ID: 39052743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance in malaria parasites of animals and man.
    Peters W
    Adv Parasitol; 1998; 41():1-62. PubMed ID: 9734291
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent insights into alteration of red blood cells by Babesia bovis: moovin' forward.
    Gohil S; Kats LM; Sturm A; Cooke BM
    Trends Parasitol; 2010 Dec; 26(12):591-9. PubMed ID: 20598944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory diagnostic of human babesiosis.].
    Kukina IV; Zelya OP; Karan LS
    Klin Lab Diagn; 2019; 64(9):560-564. PubMed ID: 31610109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.